{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:16:08Z","timestamp":1789910168313,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,6,28]],"date-time":"2010-06-28T00:00:00Z","timestamp":1277683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/aps.2010.73","type":"journal-article","created":{"date-parts":[[2010,6,28]],"date-time":"2010-06-28T08:25:31Z","timestamp":1277713531000},"page":"798-804","source":"Crossref","is-referenced-by-count":49,"title":["Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1\/MuRF1 signaling pathway in vitro"],"prefix":"10.1038","volume":"31","author":[{"given":"Bao-lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-dong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-sen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-jun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-gang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,28]]},"reference":[{"key":"BFaps201073_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/416273a","volume":"416","author":"MT Nelson","year":"2002","unstructured":"Nelson MT, Herrera GM . Molecular physiology: protecting the heart. Nature 2002; 416: 273\u20134.","journal-title":"Nature"},{"key":"BFaps201073_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA . Hypertrophy of the heart: a new therapeutic target? Circulation 2004; 109: 1580\u20139.","journal-title":"Circulation"},{"key":"BFaps201073_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN . Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003; 65: 45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"BFaps201073_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/01.RES.0000193563.53859.3e","volume":"97","author":"P Razeghi","year":"2005","unstructured":"Razeghi P, Taegtmeyer H . Cardiac remodeling: UPS lost in transit. Circ Res 2005; 97: 964\u20136.","journal-title":"Circ Res"},{"key":"BFaps201073_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.cardiores.2005.12.021","volume":"70","author":"O Zolk","year":"2006","unstructured":"Zolk O, Schenke C, Sarikas A . The ubiquitin-proteasome system: focus on the heart. Cardiovasc Res 2006; 70: 410\u201321.","journal-title":"Cardiovasc Res"},{"key":"BFaps201073_CR6","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1161\/01.CIR.0000096481.45105.13","volume":"108","author":"P Razeghi","year":"2003","unstructured":"Razeghi P, Sharma S, Ying J, Li YP, Stepkowski S, Reid MB, et al. Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 2003; 108: 2536\u201341.","journal-title":"Circulation"},{"key":"BFaps201073_CR7","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJM199612193352507","volume":"335","author":"WE Mitch","year":"1996","unstructured":"Mitch WE, Goldberg AL . Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335: 1897\u2013905.","journal-title":"N Engl J Med"},{"key":"BFaps201073_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.yjmcc.2006.07.015","volume":"41","author":"MS Willis","year":"2006","unstructured":"Willis MS, Patterson C . Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol Cell Cardiol 2006; 41: 567\u201379.","journal-title":"J Mol Cell Cardiol"},{"key":"BFaps201073_CR9","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.biocel.2004.11.010","volume":"37","author":"PR Cao","year":"2005","unstructured":"Cao PR, Kim HJ, Lecker SH . Ubiquitin-protein ligases in muscle wasting. Int J Biochem Cell Biol 2005; 37: 2088\u201397.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFaps201073_CR10","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704\u20138.","journal-title":"Science"},{"key":"BFaps201073_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","volume":"6","author":"BA Clarke","year":"2007","unstructured":"Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 2007; 6: 376\u201385.","journal-title":"Cell Metab"},{"key":"BFaps201073_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1096\/fj.03-0610com","volume":"18","author":"SH Lecker","year":"2004","unstructured":"Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb J 2004; 18: 39\u201351.","journal-title":"Faseb J"},{"key":"BFaps201073_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/01.RES.0000259559.48597.32","volume":"100","author":"MS Willis","year":"2007","unstructured":"Willis MS, Ike C, Li L, Wang DZ, Glass DJ, Patterson C . Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 2007; 100: 456\u20139.","journal-title":"Circ Res"},{"key":"BFaps201073_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","volume":"117","author":"D Accili","year":"2004","unstructured":"Accili D, Arden KC . FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117: 421\u20136.","journal-title":"Cell"},{"key":"BFaps201073_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCRESAHA.107.163428","volume":"102","author":"HJ Evans-Anderson","year":"2008","unstructured":"Evans-Anderson HJ, Alfieri CM, Yutzey KE . Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ Res 2008; 102: 686\u201394.","journal-title":"Circ Res"},{"key":"BFaps201073_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/mus.20442","volume":"33","author":"SC Kandarian","year":"2006","unstructured":"Kandarian SC, Jackman RW . Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 2006; 33: 155\u201365.","journal-title":"Muscle Nerve"},{"key":"BFaps201073_CR17","doi-asserted-by":"publisher","first-page":"E785","DOI":"10.1152\/ajpendo.00646.2007","volume":"295","author":"DS Waddell","year":"2008","unstructured":"Waddell DS, Baehr LM, van den Brandt J, Johnsen SA, Reichardt HM, Furlow JD, et al. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol Endocrinol Metab 2008; 295: E785\u201397.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFaps201073_CR18","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.106.637124","volume":"114","author":"YG Ni","year":"2006","unstructured":"Ni YG, Berenji K, Wang N, Oh M, Sachan N, Dey A, et al. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 2006; 114: 1159\u201368.","journal-title":"Circulation"},{"key":"BFaps201073_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki K, Zhu T, Guan KL . TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115: 577\u201390.","journal-title":"Cell"},{"key":"BFaps201073_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ceb.2005.01.006","volume":"17","author":"DG Hardie","year":"2005","unstructured":"Hardie DG . New roles for the LKB1\u2192AMPK pathway. Curr Opin Cell Biol 2005; 17: 167\u201373.","journal-title":"Curr Opin Cell Biol"},{"key":"BFaps201073_CR21","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1271\/bbb.70057","volume":"71","author":"K Nakashima","year":"2007","unstructured":"Nakashima K, Yakabe Y . AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes. Biosci Biotechnol Biochem 2007; 71: 1650\u20136.","journal-title":"Biosci Biotechnol Biochem"},{"key":"BFaps201073_CR22","doi-asserted-by":"publisher","first-page":"E1555","DOI":"10.1152\/ajpendo.00622.2006","volume":"292","author":"BJ Krawiec","year":"2007","unstructured":"Krawiec BJ, Nystrom GJ, Frost RA, Jefferson LS, Lang CH . AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells. Am J Physiol Endocrinol Metab 2007; 292: E1555\u201367.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFaps201073_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/jcb.22272","volume":"108","author":"JF Tong","year":"2009","unstructured":"Tong JF, Yan X, Zhu MJ, Du M . AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1\/Akt signaling in C2C12 myotubes. J Cell Biochem 2009; 108: 458\u201368.","journal-title":"J Cell Biochem"},{"key":"BFaps201073_CR24","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/jcb.21197","volume":"100","author":"HL Li","year":"2007","unstructured":"Li HL, Yin R, Chen D, Liu D, Wang D, Yang Q, et al. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. J Cell Biochem 2007; 100: 1086\u201399.","journal-title":"J Cell Biochem"},{"key":"BFaps201073_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejphar.2009.08.024","volume":"620","author":"RS Meng","year":"2009","unstructured":"Meng RS, Pei ZH, Yin R, Zhang CX, Chen BL, Zhang Y, et al. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway. Eur J Pharmacol 2009; 620: 63\u201370.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201073_CR26","doi-asserted-by":"publisher","first-page":"24194","DOI":"10.1074\/jbc.M802869200","volume":"283","author":"AY Chan","year":"2008","unstructured":"Chan AY, Dolinsky VW, Soltys CL, Viollet B, Baksh S, Light PE, et al. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 2008; 283: 24194\u2013201.","journal-title":"J Biol Chem"},{"key":"BFaps201073_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0003-2697(80)90076-7","volume":"104","author":"SJ Wassner","year":"1980","unstructured":"Wassner SJ, Schlitzer JL, Li JB . A rapid, sensitive method for the determination of 3-methylhistidine levels in urine and plasma using high-pressure liquid chromatography. Anal Biochem 1980; 104: 284\u20139.","journal-title":"Anal Biochem"},{"key":"BFaps201073_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<455::AID-JCP9>3.0.CO;2-K","volume":"181","author":"MG Thompson","year":"1999","unstructured":"Thompson MG, Thom A, Partridge K, Garden K, Campbell GP, Calder G, et al. Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C(2)C(12) myotubes by dexamethasone: effect of the proteasome inhibitor MG-132. J Cell Physiol 1999; 181: 455\u201361.","journal-title":"J Cell Physiol"},{"key":"BFaps201073_CR29","doi-asserted-by":"publisher","first-page":"H997","DOI":"10.1152\/ajpheart.00660.2008","volume":"296","author":"MS Willis","year":"2009","unstructured":"Willis MS, Rojas M, Li L, Selzman CH, Tang RH, Stansfield WE, et al. Muscle ring finger 1 mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol 2009; 296: H997\u2013H1006.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFaps201073_CR30","doi-asserted-by":"publisher","first-page":"18135","DOI":"10.1073\/pnas.0404341102","volume":"101","author":"V Kedar","year":"2004","unstructured":"Kedar V, McDonough H, Arya R, Li HH, Rockman HA, Patterson C . Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci USA 2004; 101: 18135\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFaps201073_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1083\/jcb.200402033","volume":"167","author":"R Arya","year":"2004","unstructured":"Arya R, Kedar V, Hwang JR, McDonough H, Li HH, Taylor J, et al. Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol 2004; 167: 1147\u201359.","journal-title":"J Cell Biol"},{"key":"BFaps201073_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/01.RES.0000258446.23525.37","volume":"100","author":"M Arad","year":"2007","unstructured":"Arad M, Seidman CE, Seidman JG . AMP-activated protein kinase in the heart: role during health and disease. Circ Res 2007; 100: 474\u201388.","journal-title":"Circ Res"},{"key":"BFaps201073_CR33","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167\u201374.","journal-title":"J Clin Invest"},{"key":"BFaps201073_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0014-5793(02)03501-9","volume":"531","author":"LG Fryer","year":"2002","unstructured":"Fryer LG, Parbu-Patel A, Carling D . Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino-4-imidazolecarboxamide riboside. FEBS Lett 2002; 531: 189\u201392.","journal-title":"FEBS Lett"},{"key":"BFaps201073_CR35","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.biocel.2005.03.012","volume":"37","author":"J Du","year":"2005","unstructured":"Du J, Hu Z, Mitch WE . Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process. Int J Biochem Cell Biol 2005; 37: 2147\u201355.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFaps201073_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","volume":"14","author":"TN Stitt","year":"2004","unstructured":"Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, et al. The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004; 14: 395\u2013403.","journal-title":"Mol Cell"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201073","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:24:38Z","timestamp":1684412678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,28]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFaps201073"],"URL":"https:\/\/doi.org\/10.1038\/aps.2010.73","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,28]]}}}